USPTO trademark

CTI BIOPHARMA

RegisteredUSPTOWord markClass 5Class 41Class 42

"CTI BIOPHARMA" is a word mark owned by Cti Biopharma Corp., filed at the USPTO on May 15, 2014. It is registered and covers classes 5, 41 and 42.

View Cti Biopharma Corp. portfolioGet this data via the API
Official USPTO record
CTI BIOPHARMA trademark as filed
As filed with the USPTO
Status
Registered
Since March 24, 2023
Filed
May 15, 2014
Registered
March 21, 2017
Expires
Not recorded
Application no.
86282220
Registration no.
5166752
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
3 classes
Ownership

Who owns CTI BIOPHARMA

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Cti Biopharma Corp.

Seattle, United States

89 trademarks in the portfolioView company

Representative

Frances M. Jagla

Christensen O'Connor Johnson Kindness PLLC

Goods and services

What the mark covers

The products and services CTI BIOPHARMA is filed for, grouped by Nice class.

  • Pharmaceutical preparations and substances for the treatment of cancer and for use in chemotherapy treatment; Pharmaceutical preparations and substances for the treatment of immunological, oncological, inflammatory and infectious diseases and disorders; Pharmaceutical preparations used for the treatment of conditions secondary to the oncologic, immunological and inflammatory diseases; Pharmaceutical preparations and substances for the management and treatment of pain accompanying either the disease process or the associated treatment regimens

  • Conducting seminars, classes, workshops, and training in the fields of pharmaceutical products and the treatment of medical disorders, the life sciences, clinical trials, health, medicine, oncology, hematology, cancer, and genetic disorders, and providing course materials in connection therewith; Online publications in the nature of articles, journals, and newsletters in the fields of pharmaceuticals and the treatment of medical disorders, the life sciences, clinical trials, health, medicine, oncology, hematology, cancer, and genetic disorders

  • Research, development, engineering, testing, product evaluation, and inspection in the field of pharmaceutical preparations and products; Pharmaceutical research and development; Providing technical consultation in the field of pharmaceutical product research and development; Medical and scientific research, namely, conducting clinical trials for others for pharmaceutical preparations used for the treatment of cancer, immunological, inflammatory and infectious diseases, and pain; Scientific research, consulting, and advice in the fields of biotechnology, pharmaceutical research and development, and the life sciences; Pharmaceutical, medical and laboratory research services in the fields of pharmaceuticals, cancer, genetic disorders, and the life sciences; Providing medical testing services for research purposes and medical and scientific research information in the fields of pharmaceuticals, the life sciences, clinical trials, medicine, oncology, hematology, cancer, disease classification, and genetic disorders; and consultation related to the foregoing

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Courtesy reminder - sec. 8 (10-yr)/sec. 9 e-mailed
  2. Notice of acceptance of sec. 8 & 15 - e-mailed
  3. Registered - sec. 8 (6-yr) accepted & sec. 15 ack.
  4. Case assigned to post registration paralegal
  5. Teas section 8 & 15 received
  6. Courtesy reminder - sec. 8 (6-yr) e-mailed
  7. Review of correspondence complete - address updated
  8. Applicant/correspondence changes (non-responsive) entered
  9. Teas change of correspondence received
  10. Attorney/dom.rep.revoked and/or appointed

10 earlier steps on the official record.

Disputes

Oppositions and cancellations

Proceedings recorded against this mark by the USPTO. Reported as recorded, not legal advice.

FAQ

About CTI BIOPHARMA

Who owns the trademark "CTI BIOPHARMA"?

The USPTO trademark "CTI BIOPHARMA" (application 86282220) is owned by Cti Biopharma Corp.

What is the status of "CTI BIOPHARMA"?

Its status at the USPTO is: registered.

When was "CTI BIOPHARMA" registered?

It was registered on March 21, 2017.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull CTI BIOPHARMA and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d29f4-99a6-77db-a8f0-a3c2e148d0f2
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d29f4-99a6-77db-a8f0-a3c2e148d0f2",
  "object": "trademark",
  "mark_text": "CTI BIOPHARMA",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "86282220",
  "filing_date": "2014-05-15",
  "nice_classes": [
    5,
    41,
    42
  ],
  "owners": [
    {
      "name": "CTI BIOPHARMA CORP.",
      "entity_id": "ent_019ebbb1-a963-70ce-a073-2bf07526f153"
    }
  ]
}